sccs_opinions
Because of the inadequate nature of the dossier submitted, the SCCP is unable to provide an adequate safety evaluation for the use of vitamin K1 (phytonadione) and its "oxide" in cosmetic products. However, as such use may cause cutaneous allergy, individuals so affected may be denied an important therapeutic agent.
Key concerns: Inadequate dossier prevents safety evaluation. Cosmetic use may cause cutaneous allergy, which could deny affected individuals an important therapeutic agent (vitamin K1).
Opinion date: 28 September 2007